
Clear guidance on formula types, safety rules, imported brands, and ingredient fears—plus when switching helps or harms—to reduce anxiety and support healthy growth.

Clear guidance on formula types, safety rules, imported brands, and ingredient fears—plus when switching helps or harms—to reduce anxiety and support healthy growth.

Cedars-Sinai Guerin Children’s launched a wearable asthma monitoring program designed to help detect worsening respiratory symptoms earlier.

The FDA extended its review of adrabetadex for infantile-onset Niemann-Pick disease type C to November 17, 2026, after a major NDA amendment.

UCLA researchers identified EPAC2 as a potential Fragile X syndrome treatment target after improving behavioral and brain activity patterns in mice.

FDA expanded approval of linaclotide for functional constipation to include children aged 2 to 5 years.

New AAP guidance calls for transparent pay practices and family-friendly policies to address gender-based pay inequities in pediatrics.

FDA approval moves adapalene 0.1% and benzoyl peroxide 2.5% gel to OTC use for acne in patients aged 12 years and older.

Ecopipam lowered relapse risk in pediatric Tourette syndrome responders in phase 3 data supporting a planned FDA submission.

In this episode of Infectious Insights, our host Tina Tan, MD, is joined by Juan C. Salazar, MD, to discuss the rise in measles cases, vaccine hesitancy, and more.

A study found no association with prenatal antibiotic use and only a modest, potentially confounded increase in type 1 diabetes risk following early childhood exposure.

Jon Farber, MD, shares his thoughts on radiocapitellar radiograph for identifying operative elbow fractures.

Adolescents spent an average of 50 minutes on smartphones during school nights, with social media accounting for most use.

Most children with food allergies can maintain adequate nutrition with proper counseling, targeted food substitutions, and routine growth monitoring.

French data suggest dual RSV immunization with RSVpreF and nirsevimab was associated with low infant RSV hospitalization rates.

Yoshi Rothman, MD, said growing leucovorin use in autism highlights the need for larger clinical trials and careful family counseling.

Phase 3 data showed vosoritide significantly improved annualized growth velocity and height outcomes in children with hypochondroplasia.

The hardest part of practicing medicine right now is not the complexity of care. It is earning trust.

Study finds leucovorin prescribing for children with autism increased more than 2,000% after national media coverage and White House promotion.

Children with anxiety, depression, and social needs had higher odds of health-related school absenteeism, according to a new study.

FDA accepted a levacetylleucine sNDA for ataxia-telangiectasia and set a September 19, 2026, target action date.

Early phase 2 data suggest zovegalisib may reduce lesion volume and improve symptoms in PIK3CA-driven vascular anomalies.

Early OTC-HOPE data link ECUR-506 to fewer hyperammonemic events in infants with neonatal-onset OTC deficiency.

BMN 401 met a biochemical end point but missed radiographic improvement in a phase 3 trial of children with ENPP1 deficiency.

Rohit P. Shenoi, MD, highlighted updated AAP drowning prevention guidance focused on supervision, swim skills, and equity.

New AAP guidance highlights layered drowning prevention strategies, including supervision, swim lessons, CPR training, and pool fencing.

After accounting for maternal mental health conditions, a new meta-analysis found no significant link between prenatal antidepressant exposure and autism or ADHD in children.

High school students who viewed tanning positively or sunscreen use negatively were less likely to practice sun safety

Hannah Murphy, PhD, of Vizient, discusses recent research that found children with diabetes had substantially higher rates of mental health disorders and suicide risk.

Researchers at Children’s Healthcare of Atlanta and Georgia Tech are testing an AI tool to detect worsening teen mental health online.

Preclinical data for Gemma's GB703 in DMD and GB221 in SMA1 highlight early gene therapy strategies, but clinical questions remain.